Power spectral analysis of heart rate variability in patients with Charcot's neuroarthropathy

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F06%3A00001216" target="_blank" >RIV/00023001:_____/06:00001216 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—

Result language
angličtina
Original language name
Power spectral analysis of heart rate variability in patients with Charcot's neuroarthropathy
Original language description
Charcot's or neuropathic osteoarthropathy is one of the most debilitating orthopedic sequelae of diabetes mellitus. Distinguishing Charcot's neuroarthropathy from clinically similar conditions may be challenging. The neurovascular theory postulates thatCharcot's neuroarthropathy may be secondary to sympathetic denervation of the lower-extremity vasculature. A convenient method for assessing autonomic neuropathy in patients with Charcot's neuroarthropathy is needed. Short-term power spectral analysis (PSA) of heart rate variability (HRV), a noninvasive and quantitative method for assessing autonomic neuropathy, may be advantageous compared with the traditionally used Ewing's cardiovascular reflex tests. However, there are limitations to the clinical use of PSA of HRV because of poor standardization. We standardized PSA of HRV and assessed autonomic neuropathy in 17 people with acute Charcot's neuroarthropathy using PSA of HRV versus Ewing's tests. More patients with
Czech name
Silová spektrální analýza variaiblity srdeční frekvence u pacientů s Charcotovou neuroartropatií
Czech description
Silová spektrální analýza, srdeční frekvence u pacientů s Charcotovou neuroartropatií

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FB - Endocrinology, diabetology, metabolism, nutrition
OECD FORD branch
—

Publication year
2006
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)